Study: Sharma 2018, Journal of Alternative and Complementary Medicine
Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial
Citation
Sharma AK, Basu I, Singh S (2018). Journal of Alternative and Complementary Medicine. PubMed id 28829155.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Ashwagandha: stress, sleep, thyroid and liver cautions Tier B moderate
B Adults aged 18 to 50 with subclinical hypothyroidism (raised TSH), one hospital in Varanasi, India (n=50)
Randomised, double-blind, placebo-controlled pilot of ashwagandha root extract 600 mg a day for 8 weeks.
TSH, T3 and T4 improved compared with placebo over 8 weeks. Four people withdrew (two from each group).
As recorded in this card: Sharma AK, Basu I, Singh S (2018), Journal of Alternative and Complementary Medicine, [primary]
Note: A small pilot at one site. NCCIH still advises people with thyroid disorders not to use ashwagandha, so this does not settle it; the two sources disagree in tone.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.